Loading clinical trials...
Loading clinical trials...
Incretin-based therapies have shown significant effects beyond those on glucose metabolism. We aim in the present study to evaluate the effects of liraglutide on several cardio-metabolic risk markers.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of Palermo
NCT03269058 · Type-2 Diabetes, Oral Antidiabetics
NCT06592950 · Type-2 Diabetes Mellitus (T2DM)
NCT01823510 · Type-2 Diabetes Mellitus, Coronary Artery Disease
NCT00651105 · Type-2 Diabetes, Healthy
NCT02671331 · Obesity, Type-2 Diabetes Mellitus
University Hospital of Palermo
Palermo
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions